Combating Illicit Xylazine Act
Latest action · Apr 7, 2023 Referred to the Subcommittee on Health.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedMar 28, 2023
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Combating Illicit Xylazine Act
This bill criminalizes the illicit use of xylazine. (Xylazine, also known as Tranq, is a sedative that is approved for use in animals. The Drug Enforcement Administration (DEA) has reported an increase in the trafficking of fentanyl mixed with xylazine.)
Specifically, the bill establishes criminal penalties for manufacturing, distributing, or dispensing, or possessing with intent to manufacture, distribute, or dispense, xylazine for illicit use (i.e., for use in humans) in accordance with the penalties for schedule III substances (up to 10 years imprisonment or, if death or serious bodily injury occurs, up to 15 years imprisonment, as well as criminal fines).
In addition, the DEA must coordinate with the Food and Drug Administration to report on the prevalence of the illicit use of xylazine, including associated supply chains. The bill also declares the illicit use of xylazine as an emerging drug threat.
Cosponsors 101
Members who signed on, in the order they did. Signatures ran from Mar 28, 2023 to Nov 21, 2024; 9 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-TX | August Pfluger | Original | Mar 28, 2023 |
| D-NH | Chris Pappas | Original | Mar 28, 2023 |
| D-PA | Chrissy Houlahan | Original | Mar 28, 2023 |
| R-NE | Don Bacon | Original | Mar 28, 2023 |
| R-CO | Doug Lamborn | Original | Mar 28, 2023 |
| D-NM | Gabe Vasquez | Original | Mar 28, 2023 |
| R-FL | Gus M. Bilirakis | Original | Mar 28, 2023 |
| R-CO | Ken Buck | Original | Mar 28, 2023 |
| D-CA | Mike Thompson | Original | Mar 28, 2023 |
| D-NH | Ann M. Kuster | Apr 6, 2023 | |
| R-VA | Ben Cline | Apr 6, 2023 | |
| R-PA | Brian K. Fitzpatrick | Apr 6, 2023 | |
| D-MD | David J. Trone | Apr 6, 2023 | |
| D-NJ | Jefferson Van Drew | Apr 6, 2023 | |
| D-MN | Angie Craig | Apr 18, 2023 | |
| D-NJ | Donald Norcross | Apr 18, 2023 | |
| D-CA | Josh Harder | Apr 18, 2023 | |
| D-MA | Lori Trahan | Apr 18, 2023 | |
| D-WA | Marie Gluesenkamp Perez | Apr 18, 2023 | |
| D-IL | Mike Quigley | Apr 18, 2023 | |
| R-NJ | Thomas H. Kean, Jr. | Apr 18, 2023 | |
| R-IA | Zachary Nunn | Apr 18, 2023 | |
| D-PA | Dwight Evans | Apr 19, 2023 | |
| D-CO | Yadira Caraveo | Apr 20, 2023 | |
| D-VA | Abigail Davis Spanberger | Apr 24, 2023 | |
| R-PR | Jenniffer González-Colón | Apr 24, 2023 | |
| R-MD | Andy Harris | Apr 26, 2023 | |
| R-OH | Brad R. Wenstrup | Apr 26, 2023 | |
| D-NC | Deborah K. Ross | Apr 26, 2023 | |
| D-CA | J. Luis Correa | Apr 26, 2023 | |
| D-CO | Joe Neguse | Apr 26, 2023 | |
| R-OR | Lori Chavez-DeRemer | Apr 26, 2023 | |
| R-CA | Mike Garcia | Apr 26, 2023 | |
| D-IL | Nikki Budzinski | Apr 26, 2023 | |
| R-SC | Ralph Norman | Apr 26, 2023 | |
| D-TN | Steve Cohen | Apr 26, 2023 | |
| D-PA | Susan Wild | Apr 26, 2023 | |
| R-FL | Aaron Bean | Apr 27, 2023 | |
| D-CA | Doris O. Matsui | Apr 27, 2023 | |
| D-CA | Eric Swalwell | Apr 27, 2023 | |
| D-NC | Kathy E. Manning | Apr 27, 2023 | |
| D-NY | Yvette D. Clarke | Apr 27, 2023 | |
| R-OK | Frank D. Lucas | Apr 28, 2023 | |
| D-PA | Madeleine Dean | Apr 28, 2023 | |
| R-KS | Tracey Mann | May 5, 2023 | |
| R-AL | Dale W. Strong | May 9, 2023 | |
| R-TX | Dan Crenshaw | May 9, 2023 | |
| R-TN | Diana Harshbarger | May 9, 2023 | |
| D-NC | Donald G. Davis | May 9, 2023 | |
| R-AZ | Juan Ciscomani | May 9, 2023 | |
| R-AR | Steve Womack | May 9, 2023 | |
| R-NJ | Christopher H. Smith | May 11, 2023 | |
| D-NJ | Josh Gottheimer | May 11, 2023 | |
| D-WA | Kim Schrier | May 11, 2023 | |
| R-OH | Mike Carey | May 11, 2023 | |
| R-NC | Richard Hudson | May 11, 2023 | |
| D-IL | Robin L. Kelly | May 11, 2023 | |
| D-CA | Nanette Diaz Barragán | May 15, 2023 | |
| R-TX | Nathaniel Moran | May 15, 2023 | |
| R-OK | Stephanie I. Bice | May 17, 2023 | |
| D-CA | Jared Huffman | May 22, 2023 | |
| R-CA | Jay Obernolte | May 22, 2023 | |
| R-IN | Jim Banks | May 22, 2023 | |
| R-FL | Neal P. Dunn | May 22, 2023 | |
| D-KS | Sharice Davids | May 22, 2023 | |
| D-CO | Brittany Pettersen | May 23, 2023 | |
| D-MD | Glenn Ivey | May 23, 2023 | |
| R-TX | Troy E. Nehls | May 23, 2023 | |
| R-TX | Wesley Hunt | May 23, 2023 | |
| D-CA | Jim Costa | May 24, 2023 | |
| R-SD | Dusty Johnson | May 25, 2023 | |
| R-IA | Mariannette Miller-Meeks | May 25, 2023 | |
| R-OH | Troy Balderson | May 25, 2023 | |
| D-CA | Linda T. Sánchez | May 30, 2023 | |
| D-MA | William R. Keating | May 30, 2023 | |
| D-FL | Darren Soto | Jun 1, 2023 | |
| D-MI | Debbie Dingell | Jun 1, 2023 | |
| D-MN | Betty McCollum | Jun 6, 2023 | |
| D-TX | Henry Cuellar | Jun 6, 2023 | |
| D-FL | Jared Moskowitz | Jun 6, 2023 | |
| D-CT | Joe Courtney | Jun 7, 2023 | |
| D-WA | Marilyn Strickland | Jun 7, 2023 | |
| R-WI | Bryan Steil | Jun 12, 2023 | |
| D-CA | John Garamendi | Jun 12, 2023 | |
| D-PA | Matt Cartwright | Jun 12, 2023 | |
| D-RI | Seth Magaziner | Jun 13, 2023 | |
| D-IL | Eric Sorensen | Jun 14, 2023 | |
| R-TX | Randy K. Weber, Sr. | Jun 21, 2023 | |
| R-ID | Michael K. Simpson | Jul 11, 2023 | |
| D-IL | Bradley Scott Schneider | Sep 5, 2023 | |
| D-PA | Christopher R. Deluzio | Sep 5, 2023 | |
| D-VI | Stacey E. Plaskett | Sep 5, 2023 | |
| D-WA | Suzan K. DelBene | Sep 5, 2023 | |
| R-TX | Monica De La Cruz | Sep 22, 2023 | |
| R-NY | Nicole Malliotakis | Sep 27, 2023 | |
| D-CA | Norma J. Torres | Dec 11, 2023 | |
| D-CA | Mark DeSaulnier | Jan 30, 2024 | |
| R-KY | Brett Guthrie | Mar 6, 2024 | |
| R-NY | Michael Lawler | May 31, 2024 | |
| R-CA | Vince Fong | Jul 10, 2024 | |
| R-IN | Greg Pence | Nov 21, 2024 |
Committees 2
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Mar 28, 2023 |
| Health Subcommittee | Referred Apr 7, 2023 | |
| House | Judiciary Committee | Referred Mar 28, 2023 |
Actions 3
Everything that happened, newest first.
- Apr 7, 2023Referred to the Subcommittee on Health.
- Mar 28, 2023Introduced in House
- Mar 28, 2023Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 169, no. 56, March 28, 2023, page H1529.
Printed hearings 2
Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.
| Number | Hearing | Committee | Held |
|---|---|---|---|
| Serial No. 118-50 | RESPONDING TO AMERICA'S OVERDOSE CRISIS: AN EXAMINATION OF LEGISLATION TO BUILD UPON THE SUPPORT ACT232 pages | Energy and Commerce Committee | Jun 21, 2023 |
| Serial No. 118-12 | A REVIEW OF ANIMAL AGRICULTURE STAKEHOLDER PRIORITIES97 pages | Agriculture Committee | May 17, 2023 |
CRS reports 2
Congressional Research Service work that CRS links to this bill or the law it became, newest first.
Cite it 2
Products on other subjects that cite it, usually among other measures.
| Product | Title | Kind | Published |
|---|---|---|---|
| R45948 | The Controlled Substances Act (CSA): A Legal Overview for the 119th Congress | Report | Jan 22, 2025 |
| LSB11202 | Xylazine and the Controlled Substances Act: Legal Considerations for Congress | Insight | Jul 19, 2024 |
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| S 993 | Combating Illicit Xylazine Act | Identical bill | Jan 11, 2024 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To prohibit certain uses of xylazine, and for other purposes.
- Short Title(s) as Introduced
- Combating Illicit Xylazine Act
Subjects
Assigned by the Library of Congress. Policy area: Crime and Law Enforcement.
Text 1
Each version as it was printed, newest first.
- Mar 28, 2023Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.
